Abstract:Raised dermal scars including hypertrophic, and keloid scars as well as scalp-associated fibrosing Folliculitis Keloidalis Nuchae (FKN) are a group of fibrotic raised dermal lesions that mostly occur following cutaneous injury. They are characterized by increased extracellular matrix (ECM) deposition, primarily excessive collagen type 1 production by hyperproliferative fibroblasts. The extent of ECM deposition is thought to be proportional to the severity of local skin inflammation leading to excessive fibrosis of the dermis. Due to a lack of suitable study models, therapy for raised dermal scars remains ill-defined. Immune cells and their associated markers have been strongly associated with dermal fibrosis. Therefore, modulation of the immune system and use of anti-inflammatory cytokines are of potential interest in the management of dermal fibrosis. In this review, we will discuss the importance of immune factors in the pathogenesis of raised dermal scarring. The aim here is to provide an up-to-date comprehensive review of the literature, from PubMed, Scopus, and other relevant search engines in order to describe the known immunological factors associated with raised dermal scarring. The importance of immune cells including mast cells, macrophages, lymphocytes, and relevant molecules such as cytokines, chemokines, and growth factors, antibodies, transcription factors, and other immune-associated molecules as well as tissue lymphoid aggregates identified within raised dermal scars will be presented. A growing body of evidence points to a shift from proinflammatory Th1 response to regulatory/anti-inflammatory Th2 response being associated with the development of fibrogenesis in raised dermal scarring. In summary, a better understanding of immune cells and associated molecular markers in dermal fibrosis will likely enable future development of potential immune-modulated therapeutic, diagnostic, and theranostic targets in raised dermal scarring.

An Update on Molecular Mechanisms of Scarring—A Narrative Review

Comprehensive Modular Analyses of Scar Subtypes Illuminate Underlying Molecular Mechanisms and Potential Therapeutic Targets.

The Pathophysiology and Management of Pathologic Scarring-a Contemporary Review

Fibroblasts and endothelial cells interplay drives hypertrophic scar formation: Insights from in vitro and in vivo models

Keloids and hypertrophic scars: update and future directions.

Scarring Skin: Mechanisms and Therapies

Mechanisms and Therapies

Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation

Endothelial Dysfunction and Mechanobiology in Pathological Cutaneous Scarring: Lessons Learned from Soft Tissue Fibrosis

Toward understanding scarless skin wound healing and pathological scarring

Molecular Changes Underlying Hypertrophic Scarring Following Burns Involve Specific Deregulations at All Wound Healing Stages (Inflammation, Proliferation and Maturation)

The Molecular Mechanisms Involved in the Hypertrophic Scars Post-Burn Injury

Current Progress in Understanding the Molecular Pathogenesis of Burn Scar Contracture

Biological approaches for hypertrophic scars

Direct And Indirect Roles Of Macrophages In Hypertrophic Scar Formation

Role of Inflammasomes in Keloids and Hypertrophic Scars—Lessons Learned from Chronic Diabetic Wounds and Skin Fibrosis

Immune cells and associated molecular markers in dermal fibrosis with focus on raised cutaneous scars

TGF-β: A Fibrotic Factor in Wound Scarring and a Potential Target for Anti- Scarring Gene Therapy

Inflammation in Wound Healing and Pathological Scarring

[Research Advances on the Role and Mechanism of Inflammatory Response in the Formation of Hypertrophic Scars and Keloids].

Molecular mechanism of myofibroblast formation and strategies for clinical drugs treatments in hypertrophic scars